|By Marketwired .||
|June 6, 2014 12:57 PM EDT||
NEW YORK, NY -- (Marketwired) -- 06/06/14 -- According to a new study presented at the American Urological Association (AUA) annual meeting this month, a large percentage of men who undergo prostate cancer treatment experience long-term side effects. In a review of patient responses after robotic prostate surgery, radiotherapy, and hormone therapy, a Swedish study found high rates of erectile dysfunction (ED), urinary leakage, and bowel issues nearly 12 years after prostate cancer diagnosis.
David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, conducted a similar study of his own robot-assisted laparoscopic prostatectomy (RALP) patients in 2013. During that review, Dr. Samadi's patients reported a near-90 percent satisfaction rate with their decision to undergo Samadi Modified Advanced Robotic Technique (SMART) Surgery for prostate removal.
While the latest study, presented at this year's AUA meeting, highlights potential risks associated with prostate cancer treatment, Dr. Samadi points out some key caveats. "They're looking at men who underwent radical prostatectomy twelve years ago, and there is no mention of minimally-invasive robotic surgery being used," he said. "Additionally, the follow-up timeframe puts these men in their mid-80s at the youngest; a time when erection issues often occur even in the absence of prostate cancer or treatment."
The Swedish respondents who had radiotherapy for prostate cancer reported the highest rates of urinary urgency and were the only group to report bowel dysfunction. In contrast, radical prostatectomy patients reported decreased urinary symptoms. The multi-modal therapy patients, in particular those who underwent all three prostate cancer treatments, reported the highest rates of adverse side effects. http://www.jurology.com/article/S0022-5347%2814%2901235-X/fulltext
In last year's Samadi satisfaction study, patients were asked to assess their post-surgery status based on factors such as sexual function, urinary control, and length of hospital stay. Dr. Samadi's research findings appear online in Urologic Oncology, http://www.urologiconcology.org/article/S1078-1439%2813%2900453-5/abstract.s
To date, Dr. Samadi has performed more than 5,600 successful robotic prostate removal surgeries. With adherence to post-surgery recommendations, 96 percent of his patients regain urinary control in just two to three months and 85 percent regain sexual potency within 12-24 months.
"Today, nerve-sparing robotic techniques like SMART Surgery yield improved recovery results and quality of life post-treatment," said Dr. Samadi. "We've made great strides in definitively treating prostate cancer and helping men enjoy long, satisfying lives."
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2611907
David B. Samadi, M.D
Chairman of Urology
Chief of Robotic Surgery at Lenox Hill Hospital
485 Madison Avenue
New York, NY 10022